ASPREE临床试验中数据质量挑战的克服
ASPREE试验开发了AWARD数据套件以支持数据收集者,通过比较关键功能实施前后的基线数据评估系统设计对数据质量的影响。实施用户驱动功能后,员工错误从0.3%降至0.01%,超出范围数据录入从0.14%降至0.04%,方案偏离从0.4%降至0.08%。
要点
- 用户驱动功能可显著降低员工错误、超出范围数据录入和方案偏离。
- AWARD系统中96.6%的数据值质量合格,缺失数据占3.4%。
- 设计支持数据收集者的技术可提升社区临床试验数据质量。
核心结论
- AWARD套件证明设计支持数据收集者的技术可缓解已知的数据质量差的原因并产生更高质量的数据。
研究设计与样本
- ASPREE试验开发了AWARD数据套件,通过比较关键功能实施前(n=1000)与实施后(n=18,114)收集的基线数据评估设计特征的影响。
主要发现
- 实施用户驱动功能后,员工错误从0.3%降至0.01%,超出范围数据录入从0.14%降至0.04%,方案偏离从0.4%降至0.08%。
- 参与者未出席预定研究活动是数据缺失最常见的原因。
- ASPREE中数据清理相关成本低于其他试验报告中的预期。
临床怎么用
- 支持预定活动执行(而不仅是传统数据录入)的健康IT产品可增强社区临床试验。
- 标准化的数据质量报告框架有助于临床试验间的比较。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Large-scale studies risk generating inaccurate and missing data due to the complexity of data collection. Technology has the potential to improve data quality by providing operational support to data collectors. However, this potential is under-explored in community-based trials. The Aspirin in reducing events in the elderly (ASPREE) trial developed a data suite that was specifically designed to support data collectors: the ASPREE Web Accessible Relational Database (AWARD). This paper describes AWARD and the impact of system design on data quality. METHODS: AWARD's operational requirements, conceptual design, key challenges and design solutions for data quality are presented. Impact of design features is assessed through comparison of baseline data collected prior to implementation of key functionality (n = 1000) with data collected post implementation (n = 18,114). Overall data quality is assessed according to data category. RESULTS: At baseline, implementation of user-driven functionality reduced staff error (from 0.3% to 0.01%), out-of-range data entry (from 0.14% to 0.04%) and protocol deviations (from 0.4% to 0.08%). In the longitudinal data set, which contained more than 39 million data values collected within AWARD, 96.6% of data values were entered within specified query range or found to be accurate upon querying. The remaining data were missing (3.4%). Participant non-attendance at scheduled study activity was the most common cause of missing data. Costs associated with cleaning data in ASPREE were lower than expected compared with reports from other trials. CONCLUSIONS: Clinical trials undertake complex operational activity in order to collect data, but technology rarely provides sufficient support. We find the AWARD suite provides proof of principle that designing technology to support data collectors can mitigate known causes of poor data quality and produce higher-quality data. Health information technology (IT) products that support the conduct of scheduled activity in addition to traditional data entry will enhance community-based clinical trials. A standardised framework for reporting data quality would aid comparisons across clinical trials. TRIAL REGISTRATION: International Standard Randomized Controlled Trial Number Register, ISRCTN83772183. Registered on 3 March 2005.
引用
- Lockery JE, Collyer TA, Reid CM, et al. Overcoming challenges to data quality in the ASPREE clinical trial. Trials. 2019. PMID: 31815652. doi:10.1186/s13063-019-3789-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。